Email This Article
Headlines & Perspectives
Anemic Amgen Loses Status as No. 2 Biotech
By
Elizabeth Trotta
03/20/08 - 12:39 PM EDT
Gilead now has the second-highest market cap in the sector, behind Genentech.
The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.

BEAT THE STREET GAME:







